Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Bin Xiao"'
Autor:
Jian-Ying Chen, Sheng-Zhi Jiang, Xia Guo, Qiao Li, Jie-Rou Huang, Hui Rao, Li-Hua Zhang, Bin Xiao
Publikováno v:
Autoimmunity. 54(7)
The dysregulated microRNAs (miRNAs) are implicated in the malignancy of lupus nephritis (LN). This work aims to analyse the effect and mechanism of miR-146b-5p in lipopolysaccharides (LPS)-induced model of LN in vitro. The serum samples of LN patient
Autor:
Jing Su, Xiao-Ying Ji, Yina Wang, Bin Xiao, Xudong Xiang, Shaokun Liu, Guyi Wang, Haiyun Dong, Xianghong Yan, Su-bo Gong
Publikováno v:
Mediators of Inflammation, Vol 2021 (2021)
Mediators of Inflammation
Mediators of Inflammation
Background and Purpose. Allergic asthma, a respiratory disease with high morbidity and mortality, is reported to be related to the airway allergic inflammation and autophagy-induced oxidative stress. Although the therapeutic effects of fermentate pre
Publikováno v:
Chinese Journal of Dermatology. 52
After binding to the specific insulin-like growth factor 1 receptor (IGF1R) on the surface of target tissue cells, IGF can regulate physiological processes such as apoptosis, proliferation and senescence, which are closely related to growth and devel
Autor:
Ming Li, Bin Xiao, Wenbo Hao, Haijian He, Chen Yu, Shuhong Luo, Huiqin Chen, Daxiang Chen, Daoyuan Gong, Zhenzhan Kuang, Ying-Song Wu, Yufeng Xiong, Daniel L. Rock, Mingjian Long, Fang Liu, Yong Wang
Publikováno v:
Oncotarget
Orf virus has been utilized as a safe and efficient viral vector against not only diverse infectious diseases, but also against tumors. However, the nature of the genes triggered by the vector in human cells is poorly characterized. Using RNA sequenc
Autor:
Youping Liu, Jinju Wang, Ying Cheng, Run Chen, Chunyan Duan, Chunhong Feng, Rongyang Dai, Bin Xiao, Hong Li, Fuli Yao, Hong Zhou, Jing Li, Chunyan Zhang, Xiaofang Zhao
Publikováno v:
Oncotarget
// Xiaofang Zhao 1, * , Chunyan Zhang 1, * , Hong Zhou 1, * , Bin Xiao 1 , Ying Cheng 1 , Jinju Wang 2 , Fuli Yao 1 , Chunyan Duan 1 , Run Chen 3 , Youping Liu 2 , Chunhong Feng 2 , Hong Li 1 , Jing Li 2 , Rongyang Dai 1 1 Department of Biochemistry
Rheb1-Independent Activation of mTORC1 in Mammary Tumors Occurs through Activating Mutations in mTOR
Autor:
Richard F. Lamb, Dongmei Zuo, William J. Muller, Bin Xiao, Robert D. Cardiff, Nahum Sonenberg, Alison Hirukawa
Publikováno v:
Cell Rep
Cell Reports, Vol 31, Iss 4, Pp-(2020)
Cell Reports, Vol 31, Iss 4, Pp-(2020)
Summary: Mechanistic target of rapamycin complex 1 (mTORC1) is a master modulator of cellular growth, and its aberrant regulation is recurrently documented within breast cancer. While the small GTPase Rheb1 is the canonical activator of mTORC1, Rheb1
Autor:
Yongyin He, Jingrun Lu, Jing Qu, Weiwei Li, Jianfeng Hang, Wenbo Hao, Zhenzhan Kuang, Zhaohui Sun, Ting Lei, Chun Deng, Weiyun Zhang, Bin Xiao, Linhai Li, Lidan Chen, Quan Zhou
Publikováno v:
Molecular Carcinogenesis
Glutamate Ionotropic Receptor Kainate Type Subunit 3 (GRIK3) is an important excitatory neurotransmitter receptor that plays a significant role in various neurodegenerative diseases. However, the biological functions of GRIK3 in malignancies are larg
Publikováno v:
The Journal of thoracic and cardiovascular surgery. 157(2)
Objective The aim of the study was to examine whether the cannabinoid agonist WIN55212-2 could attenuate ischemic spinal cord injury (SCI) in rats through inhibition of GAPDH/Siah1 signaling. Methods Male Sprague-Dawley rats were distributed randomly
Autor:
Hong Bin Xiao, Xiao Ni Liu, Ying Chen, Wei Yan Cai, Ya Jie Wang, Yan Guo, Xiao Gang Weng, Xi Chen, Yu Jie Li, Xiao Xin Zhu, He Fei Huang, Qi Li, Xiao Xi Kan, Qing Yang
Publikováno v:
Drug Design, Development and Therapy
Ya Jie Wang,1 Qi Li,1 Hong Bin Xiao,1 Yu Jie Li,1 Qing Yang,1 Xiao Xi Kan,1 Ying Chen,1 Xiao Ni Liu,2 Xiao Gang Weng,1 Xi Chen,1 Wei Yan Cai,1 Yan Guo,1 He Fei Huang,1 Xiao Xin Zhu11Institute of Chinese Materia Medica, China Academy of Chinese Medica
Publikováno v:
Chinese Journal of Cancer. 29:741-746
BACKGROUND AND OBJECTIVE Rosiglitazone is a peroxisome proliferators-activated receptor gamma (PPARgamma) ligand, which inhibits tumor growth by activating PPARgamma signaling pathways. Fluorouracil (5-FU) is one of the commonly used chemotherapeutic